Useful Links
Adult BNF Paediatric BNFBNF Apps (iOS and Android)
Further Medicines Management Resources
Antimicrobial guidelines
MHRA: Drug safety Update (Apr 19) Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1
MHRA: Drug safety Update (Apr 19) Pregabalin (Lyrica), gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April
MHRA: Drug safety Update (Apr 19) Belimumab (Benlysta▼): increased risk of serious psychiatric events seen in clinical trials
MHRA: Drug safety Update (Apr 19) Valproate medicines and serious harms in pregnancy: new Annual Risk Acknowledgement Form and clinical guidance from professional bodies to support compliance with the Pregnancy Prevention Programme
MHRA: Drug safety Update (Apr 19) Yellow fever vaccine (Stamaril) and fatal adverse reactions: extreme caution needed in people who may be immunosuppressed and those 60 years and older
LHP: Glycaemic control for older people
